ChemAnalyst Data Pvt Ltd

North America In Q4 2024, the  Cephalexin   market in North America displayed steady strength, with prices climbing consistently throughout the quarter. This upward trend was fueled by sustained demand from pharmaceutical manufacturers and strategic supply management by key buyers. Rising production costs and stringent regulatory compliance further bolstered the bullish sentiment, prompting U.S. buyers to accept systematic price increases, with December values reaching $58,800 per MT CFR Houston. Buying activity intensified as pharmaceutical firms moved to secure supply amid tightening conditions. Manufacturers successfully implemented price hikes, citing higher raw material and production costs. Demand from the API segment and generic drug producers remained firm, reinforcing the positive market trajectory. December saw continued price gains, supported by strong market fundamentals and year-end procurement. Domestic suppliers held firm on offers, backed by solid order books a...